UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001375
Receipt number R000001670
Scientific Title Clinical trial on the incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin: a randamized control study using transnasal endoscopy in healthy volunteers
Date of disclosure of the study information 2008/09/14
Last modified on 2013/04/14 20:06:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial on the incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin: a randamized control study using transnasal endoscopy in healthy volunteers

Acronym

Incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin

Scientific Title

Clinical trial on the incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin: a randamized control study using transnasal endoscopy in healthy volunteers

Scientific Title:Acronym

Incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin

Region

Japan


Condition

Condition

upper gastrointestinal mucosal injury

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the incidence of upper gastrointestinal injury in healthy volunteers treated with short-term low-dose aspirin using transnasal endoscopy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The number of transnasal endoscopic findings (red spots, petechiae, erosion, ulcer)

Key secondary outcomes

Symptom assessment (using GSRS)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

4

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

three kinds of placeboes for 7 days

Interventions/Control_2

Enteric-coated aspirin 100 mg/day + two kinds of placeboes for 7 days

Interventions/Control_3

Enteric-coated aspirin 100 mg/day + rebamipide 300mg/day + placebo for 7 days

Interventions/Control_4

Enteric-coated aspirin 100 mg/day + omeprazole 20mg/day + placebo for 7 days

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

a. Healthy subjects who have a normal physical examination and laboratory results
b. Obtaining informed consent
c. H.pylori negative

Key exclusion criteria

a. hemorrhage tendency
b. hypersensitivity for element of aspirin
c. previous history of aspirin induced asthma
d. previous history of peptic ulcer
e. severe blood disease
f. severe complication (malignant tumor, liver cirrhosis, renal failure, cardiac failure, etc)
g. pregnant woman,or possibility of pregnancy
h. smoker
i. Inadequate to entry judged by investigators

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Kawai

Organization

Tokyo Medical University Hospital

Division name

Endoscopy Center

Zip code


Address

6-7-1, Nishishinjuku,Shinjuku-ku, Tokyo, Japan

TEL

03-3342-6111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Takashi Kawai

Organization

Tokyo Medical University Hospital

Division name

Endoscopy Center

Zip code


Address

6-7-1, Nishishinjuku,Shinjuku-ku, Tokyo, Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Endoscopy Center, Tokyo Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Endoscopy Center, Tokyo Medical University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 09 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2008 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 09 Month 01 Day

Last follow-up date

2009 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 09 Month 14 Day

Last modified on

2013 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001670


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name